MSH2 and Leigh syndrome: Immunohistochemical analysis is more reliable for cancers belonging to the spectrum of LS [43], where the loss of expression of the heterodimers MLH1-PMS2 and/or MSH2-MSH6 represent a very reliable surrogate of dMMR [44, 45].